Eosinophilic granuloma of bone and biochemical demonstration of 49-kDa CD1a molecule expression by Langerhans-cell histiocytosis.
Histiocytic cells infiltrating the lesions in eosinophilic granuloma of bone as well as in cutaneous histiocytosis X were studied using a murine monoclonal antibody (MA) produced with proliferating cells from an eosinophilic granuloma of bone. This MA reacts with Langerhans cells (LC) of normal human skin or mucous membranes and with proliferating cells of eosinophilic granuloma of bone and skin lesions of Letter-Siwe disease, as shown by immunohistochemistry and immunogold labelling. As other murine MA's obtained after immunization with human cortical thymocytes, this MA immunoprecipitates the 49-kDa CD1a antigen found on human LC and thymic-cell surfaces but not its breakdown product after treatment with trypsin, as demonstrated by analysis of immunoelectron labelling, cytofluorometry and gel electrophoresis. This first production of a CD1a MA from an eosinophilic granuloma supports the concept of Langerhans-cell histiocytosis.
Cambazard
F
F
INSERM U209, Hôpital E. Herriot, Lyon, France.
Dezutter-Dambuyant
C
C
Staquet
M J
MJ
Schmitt
D
D
Thivolet
J
J
D015703:Antigens, CD / Q000032:analysis*; D018949:Antigens, CD1; D001847:Bone Diseases / Q000276:immunology*; D002648:Child; D004803:Eosinophilic Granuloma / Q000276:immunology*; D006646:Histiocytosis, Langerhans-Cell / Q000276:immunology*; D006801:Humans; D008297:Male
D015703:Antigens, CD; D018949:Antigens, CD1